Commentary · 27 May 2026
Conference abstractPublished 17 Oct 2016
Expression of mRNA of TLR2, TLR4 in dynamics in patients with retroperitoneal pancreatogenic phlegmon
Moscow State University, Russia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Acute pancreatitis is a common clinical condition. Excessive systemic inflammatory response syndrome (SIRS) in acute pancreatitis leads to distant organ damage and multiple organ dysfunction syndromes (MODS), which is the primary cause of morbidity and mortality in this condition. Development of in vivo experimental models of acute pancreatitis and associated systemic organ damage has enabled us to study the role played by inflammatory mediators in the pathogenesis of acute pancreatitis and associated systemic organ damage. Using these models, recent studies have established the critical role played by inflammatory mediators in acute pancreatitis and the resultant MODS. Hydrogen sulfide (H2S) plays an important role in cardiovascular, central nervous and gastrointestinal systems and has been shown to act as a vasodilator. We have also shown that H2S acts as a mediator of inflammation. Substance P is 11 amino-acid neuropeptide that is released from nerve endings in many tissues. Subsequent to its release, substance P binds to neurokinin-1 (NK-1) receptors on the surface of effector cells. Using experimental models, recent studies in our laboratory have established the critical role played by H2S and substance P in acute pancreatitis. Furthermore, early results point to the clinical relevance of this research. Studies with experimental animal models of disease will therefore help define the role of these mediators in the pathogenesis of acute pancreatitis and can lead to the development of novel therapeutic approaches for this condition.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pancreatic Disorders & Therapy.
Short communication · 27 May 2026
Immunometabolic Interactions in Pancreatic Disease: Crosstalk Between Energy Dysregulation, Immune Activation, and Tissue Dysfunction
Commentary · 27 May 2026
Microvascular Dysfunction in Pancreatic Disorders: Endothelial Injury, Perfusion Failure, and Tissue Consequences
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPancreatic Disorders & Therapy
- SubjectGastroenterology & Hepatology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Mikhail Agapov”
